Apsolol
Aspiration Pneumonia
Tang-Du HospitalSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Aspiration Pneumonia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metoclopramide Mater Misericordiae University Hospital | Phase 4 | BB |
Cromoglicic Acid University of California, San Francisco | Phase 1 | CC |
Artiss Zuyderland Medisch Centrum | Phase 4 | NR |
Same molecule, other indications
Apsolol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →